These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8187071)

  • 1. Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas.
    Bullrich F; Morris SW; Hummel M; Pileri S; Stein H; Croce CM
    Cancer Res; 1994 Jun; 54(11):2873-7. PubMed ID: 8187071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease.
    Yee HT; Ponzoni M; Merson A; Goldstein M; Scarpa A; Chilosi M; Menestrina F; Pittaluga S; de Wolf-Peeters C; Shiota M; Mori S; Frizzera G; Inghirami G
    Blood; 1996 Feb; 87(3):1081-8. PubMed ID: 8562933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
    Beylot-Barry M; Lamant L; Vergier B; de Muret A; Fraitag S; Delord B; Dubus P; Vaillant L; Delaunay M; MacGrogan G; Beylot C; de Mascarel A; Delsol G; Merlio JP
    Am J Pathol; 1996 Aug; 149(2):483-92. PubMed ID: 8701987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site.
    Ladanyi M; Cavalchire G
    Genes Chromosomes Cancer; 1996 Mar; 15(3):173-7. PubMed ID: 8721682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
    Wellmann A; Otsuki T; Vogelbruch M; Clark HM; Jaffe ES; Raffeld M
    Blood; 1995 Sep; 86(6):2321-8. PubMed ID: 7662979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
    Dirks WG; Zaborski M; Jäger K; Challier C; Shiota M; Quentmeier H; Drexler HG
    Leukemia; 1996 Jan; 10(1):142-9. PubMed ID: 8558920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
    Luthra R; Pugh WC; Waasdorp M; Morris W; Cabanillas F; Chan PK; Sarris AH
    Hematopathol Mol Hematol; 1998; 11(3-4):173-83. PubMed ID: 9844824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease.
    Xerri L; Parc P; Hassoun J; Birnbaum D
    J Pathol; 1996 Feb; 178(2):128-32. PubMed ID: 8683377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
    Sarris AH; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos MA; McBride JA; Cabanillas F; Duvic M; Deisseroth A; Morris SW; Pugh WC
    Blood; 1996 Sep; 88(5):1771-9. PubMed ID: 8781434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
    Bohling SD; Jenson SD; Crockett DK; Schumacher JA; Elenitoba-Johnson KS; Lim MS
    Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma.
    Ladanyi M
    Cancer Surv; 1997; 30():59-75. PubMed ID: 9547986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma.
    Johnson PW; Leek J; Swinbank K; Angus B; Roberts P; Markham AF; Selby PJ; MacLennan KA
    Ann Oncol; 1997; 8 Suppl 2():65-9. PubMed ID: 9209644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
    Shin HJ; Thorson P; Gu J; Katz RL
    Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions.
    Elmberger PG; Lozano MD; Weisenburger DD; Sanger W; Chan WC
    Blood; 1995 Nov; 86(9):3517-21. PubMed ID: 7579458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
    Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
    Sarris AH; Luthra R; Cabanillas F; Morris SW; Pugh WC
    Leuk Lymphoma; 1998 May; 29(5-6):507-14. PubMed ID: 9643564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease.
    Ladanyi M; Cavalchire G; Morris SW; Downing J; Filippa DA
    Am J Pathol; 1994 Dec; 145(6):1296-300. PubMed ID: 7527617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro.
    Hsu FY; Zhao Y; Anderson WF; Johnston PB
    Cancer Invest; 2007 Jun; 25(4):240-8. PubMed ID: 17612934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation t(2;5) is not a primary event in Hodgkin's disease. Simultaneous immunophenotyping and interphase cytogenetics.
    Weber-Matthiesen K; Deerberg-Wittram J; Rosenwald A; Poetsch M; Grote W; Schlegelberger B
    Am J Pathol; 1996 Aug; 149(2):463-8. PubMed ID: 8701985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
    Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.